Back to Trades
Total Value
$0
Filing Date
Jul 24, 2026
1 transaction
Trade Summary
On Jul 24, 2026, Henderson Jane, Chief Financial Officer, reported $0 of Apogee Therapeutics, Inc. (APGE) across 1 transaction. The filing covers Common Stock and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Apogee Therapeutics, Inc.
- Ticker Symbol
- APGE
- CIK
- 0001974640
Insider Information
- Name
- Henderson Jane
- Role
- Chief Financial Officer
- Location
- SAN FRANCISCO, CA
Filing Details
- Filing Date
- Jul 24, 2026
- Transaction Date
- Jul 24, 2026
- Accession Number
- 0001104659-26-086729
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 24, 2026 | Common Stock | 15,000 | — | Bona Fide Gift | — |
Want live alerts when Henderson Jane trades again?
Download Insider Trades to track APGE, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)This transaction involves a bona fide gift of securities from the reporting person to a donor advised fund.